Comparative Research Between Swenson and Soave Operations for Pediatric Patients Who Have Hirschsprung Disease

February 7, 2026 updated by: Ahmed Aouf

Comparative Study Between Swenson and Soave Techniques for Cases With Hirschsprung Disease

Hirschsprung's disease is characterized by a lack of enteric nervous system ganglion cells (aganglionosis) in a variable extent of distal bowel. It is the commonest congenital bowel motility disorder and affected neonates usually present with distal intestinal obstruction in the first few days of life. Despite the common underlying pathology of Hirschsprung disease, it has varying presentations. Infants classically present with delayed passage of meconium, feeding intolerance, and bilious emesis. In fact, 90% of children with Hirschsprung will not have passage of stool within the first 24 h of life. Neonates and infants can also present with abdominal distension, failure to thrive, enterocolitis, or bowel perforation.

Hirschsprung's disease is characterized by a variable length of distal colonic aganglionosis. In approximately 80% of cases, it is short-segment, and only involves the rectosigmoid colon. Less commonly, it can extend proximal to the sigmoid colon (15%), include the entire colon (total colonic aganglionosis, 5%), or rarely, the entire intestine (total intestinal aganglionosis). The principles of the operation are to remove the aganglionic colon and connect the normally innervated bowel just above the anus, at a level which prevents further functional obstruction, but at the same time preserves fecal continence.

The surgical treatment of Hirschsprung's disease has evolved from the historical three-stage procedure to a single-stage technique. Since then, multiple series reported its safety, efficacy, and feasibility in the management of HSCR in the neonatal period. Swenson and Bill, Soave, and Duhamel are the most common procedures for Hirschsprung's disease. However, there is a heated debate about which technique gives the best short- and long-term outcomes. There are many surgical approaches to Hirschsprung's disease, including the transabdominal approach (TAB) and transanal endorectal pull-through (TERPT). The TAB includes 4 types: the Swenson, Duhamel, Rehbein, and Soave procedures. Both the Swenson and the Soave procedures have been adapted as transanal approaches.

Transanal access is based on the traditional surgical techniques performed previously in abdominal approach. This type of surgery is used for the treatment of small children. Transanal endorectal pull-through method performed with transanal access is characterized by low invasiveness of surgery and good results of treatment.

The Swenson procedure involves the removal of the entire affected site and end-to-end anastomosis of the normal colonic anal canal. In the Soave procedure, physiological saline is injected into the rectum after cutting through the rectal muscle layer in a circular manner, while keeping the mucosa intact to the dentate line level.

Study Overview

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kafr el-Sheikh Governorate
      • Kafr ash Shaykh, Kafr el-Sheikh Governorate, Egypt, 33516
        • Kafrelsheikh University Hospitals

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Pediatric patients who are present with Hirschsprung disease.

Exclusion Criteria:

  • • Patients with severe systemic disease making anesthesia or surgery prohibitively risky (American society of Anesthesiologists (ASA) class IV.

    • Children who underwent secondary surgery from the study.
    • Total colonic aganglionosis.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Swenson procedure
full-thickness dissection is started 1 cm above the dentate line
The Swenson operation: The patient is placed in either the prone or lithotomy position and full-thickness dissection is started 1 cm above the dentate line until ganglionated bowel is encountered. Fine silk suturing is performed circumferentially at the level of that point which would be used for traction for the distal end. Another circumferential suture was performed parallel 0.5 cm distances above the original one and used for traction for the proximal intestines. The full-thickness rectal wall is truncated between the above two circumferential sutures with cautery, avoiding damaging adjacent tissues when the abdominal cavity is open. The full thickness of rectum and sigmoid colon is mobilized out though the anus and the mesenteric vessels are carefully dissected and ligatured. The colon is divided until a few centimeters above the most proximal normal site. The distal rectum is pulled eversion and is dissected anteriorly 2.5-3.5 cm above the dentate line.
Active Comparator: Soave procedure
circumferential incision is made 1cm above the dentate line in the rectal mucosa. Using blunt dissection, a submucosal plane is developed

For the operation, the patient is placed in a prone position with the pelvis elevated. As a first step to the transanal mucosectomy of the rectum, the anal canal is exposed, and a circumferential incision is made 1cm above the dentate line in the rectal mucosa. Using blunt dissection, a submucosal plane is developed placing multiple 5-0 silk traction sutures in the mucosa to facilitate its separation from the muscular wall. The submucosal plane is extended 6 cm.

The next step is to prepare the muscular sleeve through which the normoganglionic colon would be pulled. At the same site at which mucosectomy is finished, a complete incision on the rectal muscle is made to reach into the perirectal tissue. To liberate the muscular sleeve, perirectal tissue is dissected, and smooth muscle fibers of the rectum are divided circumferentially. Through this procedure, the muscular sleeve could be liberated and returned to its original position.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Operative time.
Time Frame: From enrollment to the 6 months postoperatively.
Time taken to perform the surgery completely.
From enrollment to the 6 months postoperatively.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frequency of defecation
Time Frame: From the time of enrollment to the 6 months after surgery
Number of fecal motions every day
From the time of enrollment to the 6 months after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • Dave, A., Allukian, M., Dickie, B. (2022). Hirschsprung Disease. In: Mattei, P. (eds) Fundamentals of Pediatric Surgery. Springer, Cham. https://doi.org/10.1007/978-3-031-07524-7_72

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2023

Primary Completion (Actual)

August 30, 2025

Study Completion (Actual)

September 1, 2025

Study Registration Dates

First Submitted

September 25, 2025

First Submitted That Met QC Criteria

February 7, 2026

First Posted (Actual)

February 13, 2026

Study Record Updates

Last Update Posted (Actual)

February 13, 2026

Last Update Submitted That Met QC Criteria

February 7, 2026

Last Verified

November 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The information included data of complicated cases.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Constipation

Subscribe